baber/WOPTO huggingface dataset:
Patent PT-1935929-E (PT)
Title: Sol gel process for producing protective films for polymeric substrates
Inventor: COSTA FULVIO
IPC: C08J5/18
Filed: 2006-12-19
Abstract: Sol gel process for producing protective films for polymeric substrates, the process relates to the sol-gel reaction of a metal or semi-metal alkoxide carried out in certain conditions. The sols obtained were, without limiting, spin- or dip-coated onto polymeric substrates then thermally cured into transparent-abrasion resistant coating. Such coating transmit visible light, but absorb wavelengths of ultraviolet light which cause degradation of the substrate surface and resultant adhesion-loss of the protective coating upon weathering.
Patent PT-1928431-E (PT)
Title: Controlled release pharmaceutical composition containing carvedilol
Inventor: PALFI ZOLTANNE
IPC: A61K9/50
Filed: 2006-08-23
Abstract: The present invention relates to a controlled release pharmaceutical composition in a layered pellet form containing carvedilol. The composition contains a core containing a solid organic acid, an enteric coating layer on the core, a layer containing carvedilol and a water-soluble adhesive on the surface of the enteric coating, and a dissolution controlling layer containing a mixture of a water-soluble and an enteric polymers.
Patent PT-1984438-E (PT)
Title: Antistatic polyurethane
Inventor: ORTALDA MARCO
IPC: A43B1/00
Filed: 2007-01-30
Abstract: The invention relates to an antistatic polyurethane which comprises an antistatic additive comprising an ionic liquid and a process for producing such an antistatic polymer. The invention further relates to an antistatic shoe sole comprising an antistatic polyurethane according to the invention and the use of an ionic liquid as antistatic additive for polyurethane.
Patent PT-1968331-E (PT)
Title: Nsapi allocation for mbms
Inventor: VEREN CHRISTIAN HERRERO
IPC: H04L12/18
Filed: 2005-11-04
Abstract: The method and apparatus described herein enables a mobile station to subscribe to a larger number of multi-cast services than provided by a conventional wireless network. The network establishes a multi-cast communication session and allocates a NSAPI to the communication session during a data transfer phase. Subsequently, the network transmits the multi-cast data during the established communication session.
Patent PT-2231633-E (PT)
Title: Antitumoral compounds
Inventor: URBANO CRISTINA MATEO
IPC: A61K31/351
Filed: 2008-12-19
Abstract: A compound of general formula (I)   
wherein A, Y, W, R 1 , R 2 , R 3 , R 4 , R 5 , and R 6  take various meanings for use in the treatment of cancer.
Patent PT-2435266-E (PT)
Title: Window pane with reduced double-image effect
Inventor: THELLIER HERVE
IPC: B60J1/00
Filed: 2010-05-19
Abstract: The invention relates to a curved glass pane, made of float glass, the area of a main face of which is greater than 1.5 m2 and the product of its two depths of bending is greater than 3000 mm2, and such that its point located on the normal to its surface passing through its center of gravity has a radius of curvature of less than 3 m in any direction, the variation in its thickness in the longitudinal float direction being less than 10 μm over 500 mm. This pane may be assembled into laminated glazing of the automobile windshield type. Such a windshield has a very small amount of double imaging even when it is fitted into the vehicle so as to be close to the horizontal.
Patent PT-705204-E (PT)
Inventor: BERNDT DIETER
IPC: B65D75/48
Filed: 1994-07-02
Abstract: Proposed is a sachet for individual doses of liquid drugs intended for oral administration. The sachet is characterized in that the drug is contained in so-called stick packs (1). This type of packaging makes the drugs easier to take and increases patient compliance.
Patent PT-684240-E (PT)
Inventor: JOHNSON WILLIAM HENRY
IPC: A61K31/454
Filed: 1995-04-12
Abstract: The invention provides hydroxamic acid derivatives of the general formula <CHEM> wherein R<1> represents cyclopropyl, cyclobutyl, cyclopentyl or cyclohexyl; R<2> represents a saturated 5- to 8-membered monocyclic or bridged N-heterocyclic ring which is attached via the N atom and which, when it is monocyclic, optionally contains NR<4>, O, S, SO or SO2 as a ring member and/or is optionally substituted on one or more C atoms by hydroxy, lower alkyl, lower alkoxy, oxo, ketalized oxo, amino, mono(lower alkyl)amino, di(lower alkyl)amino,carboxy, lower alkoxycarbonyl, hydroxy-methyl, lower alkoxymethyl, carbamoyl, mono(lower alkyl)-carbamoyl, di(lower alkyl)carbamoyl or hydroxyimino; R<3> represents a 5- or 6-membered N-heterocyclic ring which (a) is attached via the N atom, (b) optionally contains N, O and/or S, SO or SO2 as an additional ring member, (c) is substituted by oxo on one or both C atoms adjacent to the linking N atom and (d) is optionally benz-fused or optionally substituted on one or more other C atoms by lower alkyl or oxo and/or on any additional N atom(s) by lower alkyl or aryl; R<4> represents hydrogen, lower alkyl, aryl, aralkyl or a protecting group; m stands for 1 or 2 and n stands for 1-4, and pharmaceutically acceptable salts thereof, which are collagenase inhibitors useful in the control or prevention of degenerative joint diseases such as rheumatoid arthritis and osteoarthritis or in the treatment of invasive tumours, atherosclerosis or multiple sclerosis. They can be manufactured either by hydroxamidating a corresponding novel carboxylic acid or by deprotecting a corresponding novel benzyloxycarbamoyl compound.
Patent PT-829275-E (PT)
Inventor: VIVIER DANIEL
IPC: A62C31/12
Filed: 1997-08-28
Abstract: The head, made with a divergent outlet (35) for the foam product, has at least two channels (36) which are fed with the fluid to be converted into foam. The channels are spaced evenly round the circumference of the head, and end at walls (37) lying perpendicular to the direction of ejection, emerging through apertures (38) at the base of the outlet (35) opposite a central boss (39) which is designed to cause the fluid flows to collide. The head is made from a moulded synthetic material with a conical outlet diverging in the direction in which the foam is ejected. It is basically in the shape of a bush with two inner conical ends, and a central section with the channels, walls and central boss which is rounded, especially hemispherical, in shape.
Patent PT-902844-E (PT)
Inventor: AFFINITO JOHN C
IPC: C23C22/83
Filed: 1997-02-21
Abstract: A rinse solution for the treatment of conversion-coated metal substrates for improving the adhesion and corrosion resistance of siccative coatings, comprising an aqueous solution of a Group IVA metal ion, namely, zirconium, titanium, hafnium, and mixtures thereof, and a phenol polymer, with the pH of the total solution about 3.5 to 5.1. A method for treating such materials by applying the rinse solution to the substrate.
Patent PT-904056-E (PT)
Inventor: OORT MICHIEL VAN
IPC: A61K9/00
Filed: 1997-03-25
Abstract: A process for dispersing medicament from an inhalator device which contains medicament particles. The process involves (i) providing an inhalator which contains at least one dose of medicament particles comprising spherical hollow particulates of respirable particle size suitable for deposition in a human being's lungs, and (ii) removing the spherical hollow particulates from the inhalator.
Patent PT-925808-E (PT)
Inventor: MILITSYN JURY ALEXANDROVICH
IPC: A62D1/06
Filed: 1997-03-14
Abstract: The disclosure relates to a method of extinguishing fires, a fire-extinguishing compound and a fire-extinguishing system. The proposed method involves the preparation of a fire-extinguishing composition containing an oxidant and a fuel-binder, placing the composition in the area of the seat of the fire, initiating a sustainable fuel oxidising reaction producing combustion products in finely dispersed aerosol form, and then allowing the aerosol medium to act on the seat of the fire. According to the invention, the compositions in the aerosol products of combustion act in the immediate area of the fuel oxidation reaction to reduce the level of toxins and lower the equilibrium temperature of complete oxidation of the fuel-binder combustion products. To achieve this, a reagent is introduced into the aerosol combustion products of the composition which promotes a reduction in the equilibrium temperature of the full oxidation reaction of the fuel-binder combustion products. The reagent used consists of thermal disintegration products of a low-energy supplementary fuel. Also proposed is a compound suitable for the proposed method. The system is provided with a reactor containing means for reducing the level of toxins in the area of combustion of the composition.
Patent PT-946621-E (PT)
Inventor: KRAUSER SCOTT F
IPC: A61K47/34
Filed: 1997-12-23
Abstract: A mixture of lipophilic and amphiphilic/hydrophilic film-forming polymers of the formula (I)R-(CO)mY1-(CH2CHR1O)n-[CONH-Z-NHCO(OCH2CHR2)n'-Y2-(CH2CHR2O)n'']p-CONH-Z-NHCO-(OCH2CHR1)n-Y1(CO)mR(I)where R represents (i) an alkyl, alkenyl or alkaryl group of from 1 to 30 carbon atoms or (ii) a polypropylene oxide group or polybutylene oxide group; R1 and R2, each, independently, represent a hydrogen atom, or a methyl or ethyl group; Z represents a divalent linking hydrocarbyl group; m is 0 or 1; when m=0, Y1 represents O, NR3 or N+R3R4X- and when m=1 Y1 represents O; Y2 represents O, NR3, N+R3R4X-, (R3NCH2CH2)t, or [(R3R4N+CH2CH2)X-]t; R3 and R4, independently, represent C1-C22 alkyl; X represents an anion; t is a positive integer; n and n', are each, independently, a positive number; and p is >/=0, provide a skin substantive, occlusive moisture barrier covering for skin or hair. When Y1 and Y2 are O the polymers are nonionic in character when Y1 or Y2 represents NR3 or N+R3R4X- the polymers are cationic in character. The compositions have a moisturizing effect by reducing transepidermal water loss. The lipophilic or amphiphilic or hydrophilic film-forming polymers may be used individually or as mixtures as a delivery system for delivering pharmacological or cosmetic agents to the skin or hair.
Patent PT-864748-E (PT)
Inventor: PATRICK BRUTSAERT
IPC: F03D9/00
Filed: 1998-03-10
Abstract: The turbine has blades (5) fixed to a support driving the rotor of a disc-type alternator (40) comprising at least one module (70) with a rotor disc and stator disc centred on the axis (45) of the support (60). The modules are assembled so that all the rotor and stator discs lie coaxially, and either the blades or the rotor discs can be mounted on a shaft. The support for the blades forms the housing of the alternator, which can have a stator disc (41) located between two rotor discs (42, 43).
Patent PT-980251-E (PT)
Inventor: NAKAGAWA KATSUMI
IPC: C07K16/36
Filed: 1998-05-08
Abstract: The invention relates to the use of tissue factor for influencing, in particular activating, the formation of blood vessels, above all for wound healing.
Patent PT-1000008-E (PT)
Inventor: MELLIN CHARLOTTA
IPC: A61P35/00
Filed: 1998-06-26
Abstract: Novel thyroid receptor ligands are provided which have the general formula (I)where R1 is alkyl of 1 to 4 carbons or cycloalkyl of 3 to 7 carbons; R2 and R3 are the same or different and are hydrogen, halogen, alkyl of 1 to 3 carbons or cycloalkyl of 3 to 5 carbons, at least one of R2 and R3 being other than hydrogen; n is an integer from 0 to 4; R4 is an aliphatic hydrocarbon, an aromatic hydrocarbon, carboxylic acid ester thereof, alkenyl carboxylic acid or ester thereof, hydroxy, halogen, cyano, or a phosphonic acid or an ester thereof, or a pharmaceutically acceptible salt thereof. A method for treating diseases associated with metabolism dysfunction or which are dependent on the expression of a T3 regulated gene, such as obesity, hypercholesterolemia, osteoporosis, hypothyroidism, and goiter, is also provided.
Patent PT-925183-E (PT)
Inventor: BRAVET JEAN-LOUIS
IPC: B32B17/10
Filed: 1998-07-10
Abstract: The invention relates to a product which is at least partly transparent and of high optical quality, equivalent to that of a glass window, which can be approved as a motor-vehicle window according to the various standards in force, and having a plastic core coated with a skin comprising at least one plastic film coated with a scratch-resistant layer; it also relates to a process for manufacturing this product and to the application of the latter as a body element, part of which forms a window, for example for motor vehicles.
Patent PT-1058683-E (PT)
Inventor: KOH JONG SUNG
IPC: C07D401/06
Filed: 1999-02-01
Abstract: The present invention relates to a novel piperidine derivative represented by formula (1) which shows an inhibitory activity against farnesyl transferase or pharmaceutically acceptable salts thereof, in which A, E and G are defined in the specification; to a process for preparation of the compound of formula (1); to an intermediate which is used in the preparation of the compound of formula (1); and to a pharmaceutical composition comprising the compound of formula (1) as an active ingredient.
Patent PT-1076662-E (PT)
Title: Polyepitope carrier protein
Inventor: RAPPUOLI RINO
IPC: A61P31/04
Filed: 1999-04-27
Abstract: The invention relates to polyepitope carrier proteins that comprise at least five CD4+ T cell epitopes, for conjugation to capsular polysaccharides. The carrier proteins are use useful as components of vaccines that can elicit a T-cell dependent immune response. These vaccines are particularly useful to confer protection against infection from encapsulated bacteria in infants between the ages of 3 months and about 2 years.
Patent SG-5892-G (SG)
Title: Fpc connector
IPC: H01R13/11
Filed: 1992-01-23
Abstract: An electrical connector for a flexible printed circuit (FPC) is composed of an insulative housing (10) containing resilient female contacts (20) accessible via an opening (11) which receives a flexible printed circuit assembly (30). The assembly is composed of a V-shaped spring member (40) to which the FPC is bonded. An area of the FPC has an exposed array of spaced conductors (33a) which mate with contact regions (22) of the contacts when the assembly is inserted into the housing through the opening after initially compressing the sections of the spring member (40) together.
Patent SG-19992-G (SG)
Title: Process for obtaining hollow structures such as ducts,grain tanks or shelters
IPC: E21D11/08
Filed: 1992-02-29
Abstract: PCT No. PCT/FR82/00177 Sec. 371 Date Jul. 15, 1983 Sec. 102(e) Date Jul. 15, 1983 PCT Filed Oct. 29, 1982 PCT Pub. No. WO83/01823 PCT Pub. Date May 26, 1983.A method for producing cylindrical hollow bodies bearing on the ground along one generatrice, of large cross sectional area, by assembling on site previously prepared longitudinal components. The method consists in determining by calculation the optimum cross-sectional profile of said hollow body as a function of known parameters concerning the site, conditions of use of said hollow body and its inherent characteristics; divising said optimum cross-sectional profile into adjacent sections each corresponding to a longitudinal component of the hollow body and together providing a substantially continuous interior surface; and giving the transverse wall section of at least some of said components a variable thickness for adapting the latter component to the stresses to be exerted thereon.
Patent SG-129892-G (SG)
Title: Chemiluminescent composition
IPC: C09K11/06
Filed: 1992-12-19
Abstract: Compositions intended to be reacted with hydrogen peroxide to produce chemiluminescent light are disclosed wherein the compositions contain an oxalate, a fluorescer and a soluble perylene dye.
Patent IE-900539-L (IE)
Title: Process for drying hydrocarbons, its application to the¹preparation of chloromethanes
IPC: C07C17/10
Filed: 1990-02-14
Abstract: Process for drying a mixture containing at least one hydrocarbon, hydrochloric acid and water, characterised in that it is placed in contact with a desiccant chosen from (i) anhydrous metal sulphates, chlorides or perchlorates or (ii) phosphorus pentoxide until the desiccant has retained most of the water. This is applied to the synthesis of chloromethanes to dry the methyl chloride leaving the head of the CH3Cl/higher chloromethanes separating column.
Patent IE-860974-L (IE)
Title: Vitamin b 12 composition
IPC: A61K9/06
Filed: 1986-04-15
Abstract: A therapeutic compsn. for nasal admin. comprises vitamin B12 in an isotonic aq. buffer at pH 4-6 contg. sufficient thickening agent so that the viscosity is 2500-6500 cps. The compsn. may also contain 1-10 wt.% humectant and 0.2-2 wt.% surfactant. The vitamin B12 is cyanocobalamin in an amt. of 50-1000 micron and the thickening agent is methyl cellulose. Typically the concn. of the B12 is 0.05-1 wt.%.
Patent FI-811246-L (FI)
Inventor: BJOERKMAN ERIK
IPC: G01N25/56
Filed: 1981-04-22
Abstract: This invention relates to a method of determining the moisture ratio of timber during the drying of the timber. At a normal drying process, which may be said to comprise a heating, a pre-drying, an after-drying, a cooling and a conditioning phase, the possibilities of calculating a correct value of the absolute moisture ratio are minimum. For determining the moisture ratio in timber during its drying it is proposed according to the invention, that the drying climate established for normal drying is disturbed during a certain period and the temperature progresses are recorded both during and after the disturbance, and the recorded values are processed in a calculation unit after a predetermined mathematic pattern.
Patent IE-871106-L (IE)
Title: Pharmaceutical formulation for oral use.
IPC: A61K31/44
Filed: 1987-04-28
Abstract: Pharmaceutical preparation containing an acid labile compound together with an alkaline reacting compound or an alkaline salt of an acid labile compound optionally together with an alkaline compound as the core material, one or more subcoating layers comprising inert reacting compounds which are soluble or rapidly disintegrating in water, or polymeric, water soluble filmforming compounds, optionally containing pH-buffering alkaline compounds and an enteric coating as well as a process for the preparation thereof and the use in the treatment of gastrointestinal diseases.
[EP0244380A2]
Patent IE-42079-L (IE)
Title: Plastics container for carbonated beverage
IPC: B65D1/00
Filed: 1975-06-26
Abstract: 1508574 Portable containers PLASTONA (JOHN WADDINGTON) Ltd 20 June 1975 [29 June 1974] 28977/74 Heading B8D A sealed thermoformed, nestable plastics container has an integral base 30 comprising an outwardly convex central portion 34 surrounded by spaced feet 32 on which container is free standing and radial-radiating strap portions 36, which extend between the feet and curve upwardly to the container side wall 12. The strap portions contain the central portion from downwardly below the plane B of the feet bottom surfaces due to creep resulting from an increase in internal container pressure. As shown, the feet are of kidney-shape to define recesses 44 which resist distortion of the base, and the base, apart from the projecting feet, is hemi- or partspherical. The container is sealed by an easyopen seamed-on metal or plastics lid (20), Fig. 6 (not shown), and contains a carbonated beverage. A de-nesting ring 16 is also provided. In another embodiment, Figs. 7-11 (not shown), the feet are of triangular axial section and are more closely spaced to define narrower strap portions. The container may be made of an acrylonitrile plastics, polyesters, or polyolefins, such polystyrene, polypropylene, or polyethylene, the latter being laminated or coated with barrier material, such as macrylic material or polyvinylidene chloride to form a gas-tight lining.
[GB1508574A]
Patent IE-851519-L (IE)
Title: Azabicycloheptanes
IPC: C07D221/22
Filed: 1985-06-19
Abstract: 1-Phenyl-3-azabicyclo[3.1.1]-heptane-2,4-diones of the formula <IMAGE>  (I)  in which R1 represents hydrogen or a saturated or unsaturated, aliphatic, cycloaliphatic, cycloaliphatic-aliphatic, aromatic or aromatic-aliphatic hydrocarbon radical having up to and including 18, preferably up to and including 12, carbon atoms, R2 represents hydrogen, lower alkyl, sulpho or acyl, R3 represents hydrogen or lower alkyl and R4 represents hydrogen, lower alkyl, phenyl or phenyl substituted by -N(R2)(R3), and salts of these compounds, have valuable pharmacological properties, are effective as aromatase inhibitors and can therefore be used for the treatment of hormone-dependent diseases, especially mammary carcinoma.
Patent IE-881619-L (IE)
Title: A pin fastened to a printed circuit board by soldering
IPC: H01R12/58
Filed: 1988-05-30
Abstract: The invention relates to a pin (21) for connecting an electrical conductor (2) to a PCB (4). The pin has a first part (24) thrust into a hole in the PCB and a second part (26), to which the electrical conductor (2) is connected by a sliding contact (8). The cross-sectional dimension (d2) of the second part (26) is greater than the cross-sectional dimension (d1) of the first part (24), and between these parts the pin (21) has a shoulder (27) with sharp edges. The hole in the circuit board is coated with a metal which is connected via tabs (22) to electrical conductors (3) of the PCB(4). The pin (21) is soldered in the hole with the aid of soldering metal (25) and flux. When the flux is heated it creeps along the surface of the pin. During soldering, the shoulder (27) with the edges prevents the flux reaching the second part (26) of the pin (21 ), the second part having contact surfaces (29) on the pin (21) against the sliding contact (8) and where the flux would be a contact resistance. The pin (21) has the advantage that its first part (24) is narrow and that the tabs (22) can have a small outside diameter. There is thus created room for a large number of conductors (3) between two adjacent pins (21).
[US5000691A]
Patent IE-901624-L (IE)
Title: Method for the synthesis of ribonucleic acid (rna)
IPC: C12Q1/6865
Filed: 1990-05-03
Abstract: The invention relates to a method for the synthesis of ribonucleic acid starting from deoxyribonucleic acid in which a target sequence is present. Said DNA is treated with restriction enzyme(s) followed by strand separation. Subsequently one uses one nucleic acid primer containing a promoter sequence coupled to a nucleotide sequence which corresponds to a part of the target sequence. The invention further relates to a test kit for synthesizing RNA.
Patent IE-861628-L (IE)
Title: Protein purification
IPC: C07K1/14
Filed: 1986-06-18
Abstract: Chromatographic procedures are individually and jointly applied to the rapid and efficient isolation of biologically active proteins and especially glycoproteins such as recombinant erythropoietin present in the medium of growth of genetically transformed mammalian host cells. Illustratively, recombinant EPO is isolated from culture fluids by reverse phase chromatography employing a C4 or C6 column and elution with ethanol. Recombinant erythropoientin may also be purified by anion exchange chromatography employing, e.g., a DEAE resin, with preliminary selective elution of contaminant materials having a lower pKa than erythropoietin from the resin under conditions mitigating against acid activated protease degradation. Practiced serially, the two chromatographic procedures allow for high yields of biologically active recombinant erythropoietin from mammalian cell culture media.
Patent IE-781749-L (IE)
Title: Adhesive composition
IPC: C09J7/02
Filed: 1978-08-30
Abstract: Pressure-sensitive adhesive compositions having improved adhesion characteristics in water comprising an elastomeric mixture consisting of natural rubber and polyisobutylene, a liquid plasticizer component and a solid tackifier component.
[US4147831A]
Patent IE-902158-L (IE)
Title: Interleukin-7 Receptors
IPC: C07K14/715
Filed: 1990-06-14
Abstract: Mammalian Interleukin-7 receptor proteins, DNAs and expression vectors encoding mammalian IL-7 receptors, and processes for producing mammalian IL-7 receptors as products of recombinant cell culture, are disclosed.